Results 251 to 260 of about 361,051 (341)
Human Cyclophilins—An Emerging Class of Drug Targets
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova +3 more
wiley +1 more source
cellMCD Effectively Discovers Drug Resistance and Sensitivity Genes for Acute Myeloid Leukemia. [PDF]
Obodo D +6 more
europepmc +1 more source
A Novel Prognostic Risk‐Scoring Model Based on
Chen Luo +6 more
openalex +1 more source
After analyzing the burden of leukemia in the elderly aged 60–89 years from 1990 to 2019 using the Global Burden of Disease database, we found that although the burden of chronic myeloid leukemia has decreased over the past 30 years, the burden of other types of leukemia has continued to increase to varying degrees.
Jing Wei, Qijian Feng, Ziyuan Lu
wiley +1 more source
Characterizing <i>KMT2A</i> Rearrangement in Acute Myeloid Leukemia: A Comprehensive Genomic Study. [PDF]
Batayneh O +12 more
europepmc +1 more source
Incidence of JAK2V617F Mutation in Patients with Acute Myeloid Leukemia
HALIME OZCAM
openalex +1 more source
Targeting a nucleotide‐sensitive groove on Hsp70 that binds the Bim BH3 helix, we integrate structures, biophysics, and SAR from peptides, fragments, and phenalene‐dicarbonitrile “wedges.” These disrupt the Hsp70–Bim complex with sub‐µM cellular engagement and in vivo activity while sparing Hsp90/mortalin.
Emadeldin M. Kamel +5 more
wiley +1 more source
Rib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series
ABSTRACT Background and Purpose Ewing sarcoma (ES) is the most prevalent malignant thoracic tumor in childhood and young adults. This study reports the outcome of a national cohort treated in an international prospective trial for a localized rib ES, with a long follow‐up.
Audrey Claren +14 more
wiley +1 more source
Aggressive Disease and Poor Clinical Outcome in CEBPα-Mutated Acute Myeloid Leukemia Patient. [PDF]
Alshammari AA +5 more
europepmc +1 more source

